Nyheter

Leif Wide får Björkénska priset

Leif Wide, professor emeritus i endokrinologisk biokemi vid Uppsala universitet och upptäckaren av bland annat moderna graviditetstest, har utsetts till mottagare av årets Björkénska pris.

Björkénska priset är ett av Uppsala universitets största vetenskapliga pris för framstående forskning. Det delades ut första gången 1902.

"Den sjukvård vi tar för given kommer förändras i grunden”

Antibiotikaresistensen är en pandemi, men en tyst och långsam sådan. Som en ångvält rullar den fram över världen och hotar att slå ut sjukvården i land efter land. Läs hela artikeln av Björn Olsen, professor i tidningen EXTRAKT, Formas.

Thuréus-priset 2014

Kungliga Vetenskaps-societetens Thuréus-pris tilldelas Professor emeritus Gunnar Ronqvist för hans upptäckt av prostasomer. Se pressmeddelandet.

Kommande disputationer

  • fredag, oktober 10, 2014 09:00 Kalmar hospital, auditorium hjärnan, Lasarettsvägen 1, Kalmar Hernández, Jorge Human Pathogens and Antibiotic Resistant Bacteria in Polar Regions. Ladda ner fulltext Mer information

Aktuella publikationer vid institutionen

  • Li, S., Shi, H., Khan, M., Caplin, M., Meyer, T. et al. (2014). Functional role of miR-196a in neuroendocrine tumor cells. Submitted. Mer information
  • Li, S., Khan, M., Caplin, M., Meyer, T., Öberg, K. et al. (2014). Circulating microRNA detection in small intestinal neuroendocrine tumor patients treated with somatostatin analogs. Submitted. Mer information
  • Hambraeus, K., Jensevik, K., Lagerqvist, B., Lindahl, B., Carlsson, R. et al. (2014). Long-term Outcome of Incomplete Revascularization after Percutaneous Coronary Intervention in the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). Circulation Submitted. Mer information
  • Perk, J., Hambraeus, K., Burell, G., Carlsson, R., Johansson, P. et al. (2014). Study of Patient Information after Percutaneous Coronary Intervention (SPCI): should prevention programmes become more effective?. EuroIntervention Epub ahead of print. Mer information

PIVUS - Prospective Investigation of the Vasculature in Uppsala Seniors

The PIVUS study started in 2001 with the primary aim to investigate the predicive power of different measurements of endothelial function and arterial compliance in a random sample of 1000 subjects aged 70 living in the community of Uppsala. As secondary aims, the study also included measurements of cardiac function and structure by ultrasound and MRI, evaluation of atherosclerosis by ultrasound and MRI, 7 day food intake recordings, detailed ECG analysis, cardiovascular autonomic function, body composition by DXA, DNA analysis and lung function, as well as a number of biochemical markers.

The inclusion of subjects in the study was completed in June 2004 by the team below:

 
          Anna Stenborg, Kerstin Marttala, Lars Lind, Jan Hall

In March 2006 a reinvesigation of the cohort at the age of 75 was started. The major measurements performed at age 70 will be repeated at age 75. In addition, we will focus on infarcts in the brain and heart, so both of these items will be investigated by brain and myocardial MRI in all subjects. Also cognitive tests are included in the reinvestigation that was completed in September 2009.Of the initial 1016 subjects, 52 had died during the 5 years and 827 attended the re-examination at age 75.

In the spring of 2011 we started the 80-year reinvestigation of the cohort. This round will continue until the summer of 2014 and we expect that 500-600 of the original sample will attend. We measure the traditional CV risk factors, 2 cognitive function tests, ultrasound of the carotid arteries and the heart, a DXA scan and an MRI scan of the brain and abdominal region.